Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001935979-22-000011
Filing Date
2022-11-09
Accepted
2022-11-09 16:19:04
Documents
70
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bhvn-20220930.htm   iXBRL 10-Q 1197549
2 EX-10.18 exhibit1018-bcarofferofemp.htm EX-10.18 78729
3 EX-31.1 a2022q3bhvnltd10-qex311.htm EX-31.1 10499
4 EX-31.2 a2022q3bhvnltd10-qex312.htm EX-31.2 10713
5 EX-32.1 a2022q3bhvnltd10-qex321.htm EX-32.1 7570
11 bcarsignedofferofemploymena.jpg GRAPHIC 133731
12 bhvn-20220930_g1.jpg GRAPHIC 9161
  Complete submission text file 0001935979-22-000011.txt   6125576

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20220930.xsd EX-101.SCH 51036
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20220930_cal.xml EX-101.CAL 51381
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20220930_def.xml EX-101.DEF 285253
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20220930_lab.xml EX-101.LAB 497477
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20220930_pre.xml EX-101.PRE 400159
64 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20220930_htm.xml XML 824854
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41477 | Film No.: 221372917
SIC: 2834 Pharmaceutical Preparations